Target intelligence / Profile preview

ADAMTS13 autoantibody-expressing B cell

Molecular classification
B cell, Immune cell, Other
01

Overview

ADAMTS13 autoantibody-expressing B cells are autoreactive B lymphocytes that produce anti-ADAMTS13 autoantibodies, primarily IgG, which inhibit ADAMTS13 enzymatic activity, induce an open ADAMTS13 conformation, and promote its clearance from circulation. These cells differentiate into antibody-producing plasma cells or memory B cells in germinal centers, driving immune-mediated thrombotic thrombocytopenic purpura (iTTP) through accumulation of ultra-large von Willebrand factor multimers, microthrombi formation, thrombocytopenia, hemolytic anemia, and organ ischemia. Autoantibodies often target multiple ADAMTS13 domains, especially spacer, cysteine-rich, and C-terminal regions, with prevalence in acute and remission phases.

Other names
anti-ADAMTS13 autoantibody-producing B cellsautoreactive B cells against ADAMTS13B lymphocytes producing anti-ADAMTS13 autoantibodies
02

Biological functions

Autoantibody productionHumoral immune responseAntigen-specific immune response
03

Disease associations

Thrombotic thrombocytopenic purpuraAutoimmune disease
04

Safety considerations

Production of pathogenic autoantibodies leading to ADAMTS13 inhibition and clearanceassociation with subclinical immune-mediated TTP

Beyond the preview

Go deeper on ADAMTS13 autoantibody-expressing B cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADAMTS13 autoantibody-expressing B cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call